Sandra M Christensen , ARNP
Nurse Practitioner • Seattle, WA
2611 Ne 125th St, Suite 100b
Seattle, WA 98125
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Sandra Christensen is listed in NPPES under Nurse Practitioner.
-
NPI assigned on December 18, 2006; this date does not establish years in practice.
-
Published CMS data list 42 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Trulicity (Dulaglutide) — 19 prescription fills, including refills.
- Fluoxetine Hcl — 12 prescription fills, including refills.
- Trazodone Hcl — 11 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See the full table · Guide: How to read Medicare Part D prescriber data
-
Fewer Part D prescriptions than 75% of clinicians listed under Nurse Practitioner in Seattle, WA (2024, 237 clinicians with data). Median for this group: 147. Middle half: 53 to 478.
Fewer Part D prescriptions than 80% of clinicians listed under Nurse Practitioner in Washington (2024, 1,099 clinicians with data). Median for this group: 277. Middle half: 74 to 877.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 20 in 2020 to 42 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
2611 Ne 125th St
Suite 100b
Seattle, WA 98125
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Nurse Practitioner: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
55 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$18,865 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $85,468.62 across 118 records.
By nature of payment (3 largest of 4)
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $45,702.38 across 39 records.
- Consulting Fee: $24,959.50 across 10 records.
- Travel and Lodging: $12,853.12 across 43 records.
Reporting-company totals (3 largest of 4)
- Novo Nordisk Inc: $50,580.69 across 54 records.
- Eli Lilly and Company: $22,083.69 across 50 records.
- Boehringer Ingelheim Pharmaceuticals, Inc.: $12,750.98 across 13 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Seattle and Washington
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Fewer Part D prescriptions than 75% of clinicians listed under Nurse Practitioner in Seattle, WA (2024, 237 clinicians with data). Median for this group: 147. Middle half: 53 to 478.
Fewer Part D prescriptions than 80% of clinicians listed under Nurse Practitioner in Washington (2024, 1,099 clinicians with data). Median for this group: 277. Middle half: 74 to 877.
Part D drug cost
Close to the middle for clinicians listed under Nurse Practitioner in Seattle, WA (2024, 237 clinicians with data). Median for this group: $9,065. Middle half: $917 to $111,867.
Close to the middle for clinicians listed under Nurse Practitioner in Washington (2024, 1,099 clinicians with data). Median for this group: $11,694. Middle half: $1,114 to $110,470.
569 active clinicians are listed under Nurse Practitioner with a practice address in Seattle, WA (2,310 in Washington).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Seattle
28.8% of these 569 clinicians have the CMS telehealth indicator.
58.7% of these 569 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 110% from 20 in 2020 to 42 in 2024.
- 2020: 20
- 2021: 75
- 2022: 59
- 2023: 106
- 2024: 42
-
30-day fills
30-day fills increased 175% from 20 in 2020 to 55 in 2024.
- 2020: 20
- 2021: 87
- 2022: 79
- 2023: 139
- 2024: 55
-
Part D drug cost
Part D drug cost went from $569 in 2020 to $18,865 in 2024.
- 2020: $569
- 2021: $10,962
- 2022: $1,032
- 2023: $75,677
- 2024: $18,865
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 641% from $11,535.84 in 2021 to $85,468.62 in 2025.
- 2021: $11,535.84
- 2022: $30,055.64
- 2023: $28,205.00
- 2024: $85,443.31
- 2025: $85,468.62
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 118 records totaling $85,468.62.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $10,720.00 |
| Novo Nordisk Inc |
Consulting Fee
Cash or cash equivalent
|
— | General | $6,352.50 |
| Novo Nordisk Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Wegovy | General | $4,042.50 |
| Novo Nordisk Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Wegovy | General | $4,042.50 |
| Novo Nordisk Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Wegovy | General | $3,877.50 |
| Novo Nordisk Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Wegovy | General | $3,547.50 |
| Novo Nordisk Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Wegovy | General | $3,547.50 |
| Novo Nordisk Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Wegovy | General | $3,382.50 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
ZEPBOUND | General | $2,500.00 |
| Novo Nordisk Inc |
Travel and Lodging
In-kind items and services
|
Wegovy | General | $1,179.72 |
| Novo Nordisk Inc |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,155.00 |
| Novo Nordisk Inc |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,138.50 |
| Novo Nordisk Inc |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,138.50 |
| Novo Nordisk Inc |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,138.50 |
| Novo Nordisk Inc |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,138.50 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
ZEPBOUND | General | $1,000.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
ZEPBOUND | General | $1,000.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
ZEPBOUND | General | $1,000.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
ZEPBOUND | General | $1,000.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
ZEPBOUND | General | $1,000.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
ZEPBOUND | General | $1,000.00 |
| Novo Nordisk Inc |
Travel and Lodging
In-kind items and services
|
Wegovy | General | $895.53 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
ZEPBOUND | General | $875.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
ZEPBOUND | General | $875.00 |
| Novo Nordisk Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Wegovy | General | $841.50 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Trulicity | Dulaglutide | 19 | 532 | $18,672.19 | — |
| Fluoxetine Hcl | Fluoxetine Hcl | 12 | 750 | $162.83 | — |
| Trazodone Hcl | Trazodone Hcl | 11 | 330 | $30.17 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 363L00000X
(1) A registered nurse provider with a graduate degree in nursing prepared for advanced practice involving independent and interdependent decision making and direct accountability for clinical judgment across the health care continuum or in a certified specialty. (2) A registered nurse who has completed additional training beyond basic nursing education and who provides primary health care services in accordance with state nurse practice laws or statutes. Tasks performed by nurse practitioners vary with practice requirements mandated by geographic, political, economic, and social factors. Nurse practitioner specialists include, but are not limited to, family nurse practitioners, gerontological nurse practitioners, pediatric nurse practitioners, obstetric-gynecologic nurse practitioners, and school nurse practitioners.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Podiatrist
Doctor of Podiatric Medicine
Dentist - Periodontics
Doctor of Dental Medicine
Chiropractor
Doctor of Chiropractic
Naturopath
Doctor of Naturopathic Medicine
Dentist - Periodontics
BDS, Master of Science
Physical Therapist
Physical Therapist, Doctor of Physical Therapy, Orthopedic Clinical Specialist
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 2611 NE 125TH ST, SUITE 100B, SEATTLE, WA 98125 (Tel: 2062292764)
Registered at 18720 81ST AVE W, EDMONDS, WA 98026 (Tel: 2062292764)
NPI status registered as active in NPPES database
Registered at 823 NE 65TH ST, SEATTLE, WA 981155539 (Tel: 2062292764)
Registered at 18720 81ST AVE W, EDMONDS, WA 980265821 (Tel: 2062292764)
Recorded as SANDRA CHRISTENSEN, ARNP
Nurse Practitioner (license number reported to NPPES: WA AP30006297)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Nurse Practitioners in Seattle
- Angela Buxton, ARNP
- Joanne Barrientos
- Lindsay Cunliffe, AGACNP-BC
- Kimberly Harlow, ARNP
- Elizabeth Thompson, ARNP
- Bridget Whelan
Mailing Address
18720 81st Ave W
Edmonds, WA 98026
Phone: 2062292764